HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa.

AbstractOBJECTIVE:
The purpose of this study was to determine whether carbidopa (Lodosyn), an inhibitor of dopa-decarboxylase that blocks the synthesis of dopamine outside the brain, is an effective antiemetic in patients with familial dysautonomia (FD) and hyperdopaminergic nausea/retching/vomiting attacks.
METHODS:
We enrolled 12 patients with FD in an open-label titration and treatment study to assess the safety of carbidopa. We then conducted a randomized, double-blind, placebo-controlled, crossover study to evaluate its antiemetic efficacy.
RESULTS:
Previous fundoplication surgery in each patient studied prevented vomiting, but all of the subjects experienced severe cyclical nausea and uncontrollable retching that was refractory to standard treatments. Carbidopa at an average daily dose of 480 mg (range 325-600 mg/day) was well tolerated. In the double-blind phase, patients experienced significantly less nausea and retching while on carbidopa than on placebo (p < 0.03 and p < 0.02, respectively). Twenty-four-hour urinary dopamine excretion was significantly lower while on carbidopa (147 ± 32 µg/gCr) than while on placebo (222 ± 41µg/gCr, p < 0.05).
CONCLUSIONS:
Carbidopa is a safe and effective antiemetic in patients with FD, likely by reducing the formation of dopamine outside the brain.
CLASSIFICATION OF EVIDENCE:
This study provides Class II evidence that carbidopa is effective in reducing nausea/retching/vomiting in patients with FD.
AuthorsLucy Norcliffe-Kaufmann, Jose Martinez, Felicia Axelrod, Horacio Kaufmann
JournalNeurology (Neurology) Vol. 80 Issue 17 Pg. 1611-7 (Apr 23 2013) ISSN: 1526-632X [Electronic] United States
PMID23553478 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiemetics
  • Dopamine Agents
  • Carbidopa
Topics
  • Adolescent
  • Adult
  • Antiemetics (therapeutic use)
  • Carbidopa (therapeutic use)
  • Child
  • Cross-Over Studies
  • Dopamine Agents (therapeutic use)
  • Double-Blind Method
  • Dysautonomia, Familial (complications, drug therapy)
  • Female
  • Humans
  • Male
  • Nausea (drug therapy, etiology)
  • Vomiting (drug therapy, etiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: